UNSPSC 51422600: Combination glucocorticoids

This classification denotes combination drugs and preparations that consist of corticosteroids that affect carbohydrate metabolism or GLUCONEO-GENESIS, liver glycogen deposition, and elevation of BLOOD SUGAR, inhibit adrenocorticotropic hormone secretion, and possess anti-inflammatory activity, and which thefore bear the name GLUCO-CORTICOIDS or GLUCOCORTICOIDS. Typical combination glucocorticoid constituents are dexamethasone and lidocaine.

UNSPSC 51422600 Combination glucocorticoids is a Class code that does not reflect the work actually being solicited under it. The single recent opportunity in the source—Seminole County, Florida's procurement of naloxone and drug deactivation systems—falls outside the scope of pharmaceutical glucocorticoid compounds. The code shows little relevant recent activity for state and local buyers in the actual glucocorticoid drug category.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, at 2:00 pm. Quarterly deliveries are required to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs included in vendor bids. The contract carries a two-year initial term with an optional one-year renewal. Vendors must comply with drug-free workplace certification, E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The procurement does not specify set-asides for disadvantaged enterprises. The contract is potentially funded through FEMA and includes federal compliance requirements under the Clean Air Act and Federal Water Pollution Control Act.